p.170 抽出テキスト

nous thromboembolism in critically ill patients. Int J Low Extrem Wounds 2022; 21: 31-40. PMID: 32527203 554. Hatano S, Strasser T, editors. Primary pulmonary hypertension: Report on a WHO meeting, Geneva, 15-17 October 1973. World Health Organization, 1975. 555. Kovacs G, Olschewski A, Berghold A, et al. Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 2012; 39: 319-328. PMID: 21885394 556. Maron BA, Hess E, Maddox TM, et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: Insights from the veterans affairs clinical assessment, reporting, and tracking program. Circulation 2016; 133: 1240-1248. PMID: 26873944 557. Zeder K, Banfi C, Steinrisser-Allex G, et al. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review. Eur Respir J 2022; 60: 2103181. PMID: 35332069 558. Kovacs G, Herve P, Barbera JA, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J 2017; 50: 1700578. PMID: 29167297 559. Zeder K, Olschewski H, Kovacs G. Updated definition of exercise pulmonary hypertension. Breathe (Sheff) 2022; 18: 220232. PMID: 36865934 560. Borlaug BA, Nishimura RA, Sorajja P, et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588-595. PMID: 20543134 561. Omote K, Hsu S, Borlaug BA. Hemodynamic assessment in heart failure with preserved ejection fraction. Cardiol Clin 2022; 40: 459- 472. PMID: 36210131 562. Eisman AS, Shah RV, Dhakal BP, et al. Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure. Circ Heart Fail 2018; 11: e004750. PMID: 29695381 563. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888-894. PMID: 19324955 564. Wolsk E, Bakkestrøm R, Thomsen JH, et al. The influence of age on hemodynamic parameters during rest and exercise in healthy individuals. JACC Heart Fail 2017; 5: 337-346. PMID: 28017352 565. Andersen MJ, Olson TP, Melenovsky V, et al. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail 2015; 8: 41-48. PMID: 25342738 566. Dorfs S, Zeh W, Hochholzer W, et al. Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction. Eur Heart J 2014; 35: 3103-3112. PMID: 25161181 567. Lewis GD, Murphy RM, Shah RV, et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011; 4: 276-285. PMID: 21292991 568. Hasler ED, Müller-Mottet S, Furian M, et al. Pressure-flow during exercise catheterization predicts survival in pulmonary hypertension. Chest 2016; 150: 57-67. PMID: 26892603 569. Ho JE, Zern EK, Lau ES, et al. Exercise pulmonary hypertension predicts clinical outcomes in patients with dyspnea on effort. J Am Coll Cardiol 2020; 75: 17-26. PMID: 31918830 570. Stamm A, Saxer S, Lichtblau M, et al. Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis. Eur Respir J 2016; 48: 1658-1667. PMID: 27824602 571. Kusunose K, Yamada H, Hotchi J, et al. Prediction of future overt pulmonary hypertension by 6-min walk stress echocardiography in patients with connective tissue disease. J Am Coll Cardiol 2015; 66: 376-384. PMID: 26205595 572. Kovacs G, Bartolome S, Denton CP, et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J 2024; 64: 2401324. PMID: 39209475 573. Gerhardt F, Fiessler E, Olsson KM, et al. Positive vasoreactivity testing in pulmonary arterial hypertension: Therapeutic consequences, treatment patterns, and outcomes in the modern management era. Circulation 2024; 149: 1549-1564. PMID: 38606558 574. Hirakawa K, Asano R, Ueda J, et al. Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment. Int J Cardiol 2024; 406: 132043. PMID: 38614366 575. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088- 1093. PMID: 14583573 576. Shirai Y, Yasuoka H, Okano Y, et al. Clinical characteristics and sur-

vival of Japanese patients with connective tissue disease and pulmo- nary arterial hypertension: a single-centre cohort. Rheumatology (Oxford) 2012; 51: 1846-1854. PMID: 22740623 577. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hyper-

tension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030. PMID: 16456139 578. Galie N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008; 68: 1049- 1066. PMID: 18484798 579. Sibomana JP, Campeche A, Carvalho-Filho RJ, et al. Schistosomiasis pulmonary arterial hypertension. Front Immunol 2020; 11: 608883. PMID: 33362796 580. Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant 2012; 31: 373-380. PMID: 22226804 581. Raghu G, Nathan SD, Behr J, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J 2015; 46: 1370-1377. PMID: 26250495 582. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167: 735-740. PMID: 12480614 583. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752. PMID: 16537877 584. Nathan SD, Shlobin OA, Ahmad S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657-663. PMID: 17356077 585. Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J 2021; 57: 2002258. PMID: 32747397 586. Xu XQ, Jing ZC. High-altitude pulmonary hypertension. Eur Respir Rev 2009; 18: 13-17. PMID: 20956117 587. 難病情報センター.特定医療費(指定難病)受給者証所持者数. https://www.nanbyou.or.jp/entry/5354 588. Tamura Y, Tamura Y, Shigeta A, et al. Adult-onset idiopathic peripheral pulmonary artery stenosis. Eur Respir J 2023; 62: 2300763. PMID: 38061784 589. Price LC, Seckl MJ, Dorfmüller P, et al. Tumoral pulmonary hypertension. Eur Respir Rev 2019; 28: 180065. PMID: 30728162 590. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223. PMID: 3605900 591. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007; 132: 373-379. PMID: 17400671 592. Bonderman D, Wexberg P, Martischnig AM, et al. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J 2011; 37: 1096-1103. PMID: 20693249 593. Klok FA, Surie S, Kempf T, et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res 2011; 128: 21-26. PMID: 21450333 594. Rich JD, Thenappan T, Freed B, et al. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol 2013; 167: 669-676. PMID: 22459397 595. Sun PY, Jiang X, Gomberg-Maitland M, et al. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. Chest 2012; 141: 374-380. PMID: 21778258 596. Ohte N, Ishizu T, Izumi C, et al. JCS Joint Working Group. JCS 2021 guideline on the clinical application of echocardiography. Circ J 2022; 86: 2045-2119. PMID: 36328514 597. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615-621. PMID: 19164700 598. D'Alto M, Di Maio M, Romeo E, et al. Echocardiographic probability of pulmonary hypertension: a validation study. Eur Respir J 2022; 60: 2102548. PMID: 34996833 599. Jankowich M, Maron BA, Choudhary G. Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines. Lancet Respir Med 2021; 9: 1185-1191. PMID: 34270923 600. Gall H, Yogeswaran A, Fuge J, et al. Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension. EClinicalMedicine 2021; 34: 100822. PMID: 33997731 601. Park JH, Kusunose K, Kwon DH, et al. Relationship between right